Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound inside the body reveals how tumors block the bile duct

NCT ID NCT05155475

Knowledge-focused Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study uses endoscopic ultrasound—a tiny ultrasound probe on a flexible tube passed through the mouth—to measure the size of the common bile duct in people with jaundice caused by pancreatic or bile duct tumors. Researchers aim to better understand how these tumors compress the bile duct, which may help guide future diagnosis and treatment. The study involves 20 adults with jaundice and high bilirubin levels who are already scheduled for an endoscopic ultrasound for biopsy or staging.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help doctors better understand how malignant tumors block the bile duct, potentially improving future diagnosis and treatment planning.
What could go wrong
This is a small, observational study with only 20 participants, so results may not apply to all patients. It does not test a new treatment, so it will not directly improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

20 people

The number who actually took part.

Started

Jun 2019

Finished

Dec 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients over 18 years old, with jaundice

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with jaundice and an injury to the head of the pancreas recommended for EUS-guided tissue acquisition or staging * Patients with jaundice and distal CBD lesion suggestive of cholangiocarcinoma or Vater's ampulla carcinoma recommended for EUS-guided tissue acquisition or staging * Serum bilirubin level ≥ 3 mg / dl * Age ≥ 18 years old * Subject affiliated or beneficiary of a social security scheme. * Subject having been informed of this study and having given his no objection Exclusion Criteria: * Presence of altered anatomy due to previous gastric surgery (Billroth II or Roux-en-Y anastomosis) * Sphincterotomy performed previously, plastic biliary stent or metal stent placement * Percutaneous drainage of the bile ducts performed previously * Pregnant, breastfeeding or parturient woman * Protected patients: Adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision; hospitalized without consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ampullary carcinoma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma of the ampulla of vater distal biliary tract carcinoma exocrine pancreatic carcinoma obstructive jaundice

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bilio-pancreatic tumor Obstructive jaundice

Contacts and locations

Locations

  • Hôpital Jean Mermoz

    Lyon, 69008 Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.